Pancreatic cancer treatment can be challenging, especially when hidden metastases (small areas of cancer that don’t show up easily on scans) are present. A study reviewed records of 366 patients who had surgery after chemotherapy. They found that 15% had these hidden metastases, often in the liver. Factors like high CA19-9 levels and certain changes in the liver and lymph nodes were linked to a higher chance of these metastases. The study highlights the need for early and accurate detection of metastases to improve treatment plans and outcomes. For those with hidden metastases, survival averaged about 15 months. It’s crucial to talk with your doctor about the best strategies for monitoring and managing your condition. Read the full study
Leave a Reply